ClinicalTrials.gov
ClinicalTrials.gov Menu

First in Man Clinical Study to Investigate Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of CM3.1-AC100

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01028521
Recruitment Status : Completed
First Posted : December 9, 2009
Last Update Posted : July 15, 2010
Sponsor:
Information provided by:
CellMed AG, a subsidiary of BTG plc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2010
  Actual Study Completion Date : May 2010